MedTrace Logo

Dumping Syndrome After Operation of Esophageal Atresia Type III

NCT02525705 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2026-05-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the prevalence at 3.5 months of age of dumping syndrome in children operated at birth for oesophageal atresia type III et IV.

Conditions

  • Oesophageal Atresia
  • Dumping Syndrome

Interventions

BIOLOGICAL

Oral Glucose

1.75g/kg of glucose is orally taken by the patient. Capillary glycemia is systematically realised before ingestion (H0) and after 30, 60, 90, 120, 180 and 240 min and/or if clinical signs of hypoglycemia are presented by the patient.

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Laurent Michaud, MD · University Hospital, Lille

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
14 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-14
Primary Completion
2018-01-15
Completion
2018-01-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02525705 on ClinicalTrials.gov